The global pet cancer therapeutics market is anticipated to grow at a significant CAGR during the -forecast period (2021-2027). The major factors that are influencing the growth of the market include the growing prevalence of several types of cancers in cats and dogs, as well as an increase in animal health awareness. The most common cancers in cats include leukaemia and lymphoma. Cancer is one of the major causes of mortality in pets, mainly in dogs that are older than 10 years. The success rate of various treatments in preventing and curing neoplasia, and cancer in the pet population, has observed a significant rise over the past few years, as a result of the recent advancements in early screening, diagnosis, and treatment methods.
To Request a Sample of our Report on Global Pet Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/pet-cancer-therapeutics-market
According to FETCH a Cure, a non-profit organization, an estimated 6 million dogs were diagnosed with cancer in 2019 across the globe. This indicates that there is an increasing need for cancer treatment in dogs, which is likely to accelerate the growth of the market during the forecast period. Moreover, the other factors that are expected to boost the market include an increase in the adoption of dogs across the globe and an increase in R&D initiatives regarding pet cancer management by the players, which are expected to propel the market growth during the forecast period. For instance, in April 2019, Elanco signed a development and commercialization agreement with VetDC for Tanovea-CA1, and, the first US Food and Drug Administration (FDA) conditionally approved canine lymphoma treatment.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Boehringer Ingelheim GmbH (Merial), Zoetis Inc., and Elanco Animal Health Inc., among others.
A full Report of Global Pet Cancer Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/pet-cancer-therapeutics-market
Global Pet Cancer Therapeutics Market Report by Segment
By Therapy
- Chemotherapy
- Radiation therapy
- Immunotherapy
- Others
By Animal
- Dogs
- Cats
- Others
By Application
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Others
Global Pet Cancer Therapeutics Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pet-cancer-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
